Apollo names Christopher J. Gostout as chief medical officer
Dr. Gostout brings with him more than 30 years of experience in gastroenterology and hepatology with the Mayo Clinic in Rochester, Minnesota, and is a recognized key opinion leader on minimally invasive endolumenal and surgical procedures.
Prior to joining Apollo in this capacity, Dr. Gostout grew a successful gastroenterologist practice at the Mayo Clinic, Rochester, Minnesota, in the Division of Gastroenterology and Hepatology, with a joint appointment in the Department of Surgery, from which he retired on December 31, 2016.
In addition to his medical practice, Dr. Gostout previously provided consulting Chief Medical Officer services to Apollo.
He was a Professor of Medicine in the Mayo Clinic College of Medicine and the Director of the Developmental Endoscopy and Research Unit, and the founder of The Mayo Clinic GI Bleeding Team and the Developmental Endoscopy Unit.
Dr. Gostout has previously been the President of the American Society for Gastrointestinal Endoscopy (ASGE) and has been responsible for the development of the renowned ASGE ITT center.
He has also been a member of The Board of Trustees in the American College of Gastroenterology.
His areas of specialty interest, research, and publication include endoscope development, gastrointestinal bleeding, management of pancreaticobiliary disease, advanced endoscopic imaging, endotherapy of obesity, and endoscopic resection and tissue closure techniques. ■
What to read next
LATEST MOVES FROM Texas
- Texas Instruments elects Brian Crutcher to board
- Integera appoints Joseph W. Dziedzic as permanent CEO
- ConocoPhillips appoints Sharmila Mulligan to board
- Summit Hotel Properties appoints Hope Taitz as independent director
- Commercial Metals appoints Barbara Smith as CEO
More inside POST
ReneSola Q1 revenue $156.6 million Earnings
When your team gives 140 percent Leadership